Coronary artery surgery for ischaemic heart failure: the surgeon's view

Michael Edward Lewis1, Michael Paul Ian Pitt, Robert Stuart Bonser

  • 1Department of Cardiac Surgery, Queen Elizabeth Hospital Medical Centre, Edgbaston, Birmingham, B15 2TH.

Insights

Severe heart failure patients often have poor survival despite medical advances. Myocardial hibernation, a condition where heart muscle dysfunction is reversible, may offer new treatment options through revascularisation.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Myocardial Viability

Background:

  • Severe heart failure management remains challenging, with limited donor organs for transplantation.
  • Coronary artery disease can cause ventricular dysfunction, which is not always irreversible.
  • Myocardial hibernation describes reversible ventricular dysfunction in heart failure patients.

Purpose of the Study:

  • To explore myocardial hibernation as a potential therapeutic target in heart failure.
  • To evaluate revascularisation as a treatment strategy for heart failure with hibernating myocardium.

Main Methods:

  • Identifying patients with ventricular dysfunction secondary to coronary artery disease.
  • Assessing myocardial viability to detect signs of hibernation.
  • Considering revascularisation procedures for eligible patients.

Main Results:

  • Revascularisation in patients with myocardial hibernation can improve ventricular function.
  • This approach may offer an alternative treatment for specific heart failure populations.

Conclusions:

  • Myocardial hibernation is a critical factor in managing heart failure.
  • Revascularisation presents a promising therapeutic avenue for heart failure patients with hibernating myocardium.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...